 "Shilpa Medicare extends rally post Q2 results")
Shilpa Medicare has rallied 10% to Rs 535, extending its previous day’s 2.5% gain on the BSE, after the company reported 28% year on year (YoY) jump in consolidated net profit at Rs 22.22 crore for the quarter ended September 30, 2015 (Q2). The pharmaceutical company had profit of Rs 17.30 crore in the same quarter year ago.
Net sales of the company grew 12% at Rs 173 crore on YoY basis.
EBITDA (earnings before interest, tax, depreciation, and amortization) margin expanded by nearly 400 basis points to 21.61% from 18%.
The stock hit a high of Rs 553 on the BSE and has seen an over three-fold jump in trading volumes. A combined 70,881 shares changed hands against an average sub 20,000 shares that were traded daily in past two weeks on the BSE and NSE.
Net sales of the company grew 12% at Rs 173 crore on YoY basis.
EBITDA (earnings before interest, tax, depreciation, and amortization) margin expanded by nearly 400 basis points to 21.61% from 18%.
The stock hit a high of Rs 553 on the BSE and has seen an over three-fold jump in trading volumes. A combined 70,881 shares changed hands against an average sub 20,000 shares that were traded daily in past two weeks on the BSE and NSE.
